ACIU (acimmune.com) Net Profit

Official company branding of AC Immune SA (ACIU)

AC Immune (ACIU) specializes in developing innovative treatments for brain pathologies. The business strategy relies on dementia diagnostics, while product portfolio risks are partially mitigated through collaborations with industry behemoths, and the indicator stands at -0.05. This stock price chart clearly demonstrates the company's market valuation. To optimize processes, the firm outsources drug manufacturing and testing to external contractors, focusing on Alzheimer's therapy.

AC Immune Inc (ACIU): Net Income from 07/04/2022 to 10/29/2026

Analytical breakdowns and data insights for company AC Immune SA (ACIU)

- stock value and consensus price forecast:
Market Price AC Immune Inc|ACIU - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization AC Immune Inc|ACIU - Enterprise Value
- book capitalization data:
Accounting Value per Share AC Immune|ACIU - Company Net Assets|Market Value to Book Value acimmune.com|ACIU - Company Total Assets
- debt burden and liquidity indicators:
Total Debt to Capital Coefficient AC Immune|ACIU - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio AC Immune S.A.|ACIU - Company Debts|Debt to Book Value AC Immune Inc|ACIU - Company Long-Term Liabilities|Company Short-Term Debts AC Immune|Immediate Liquidity Ratio acimmune.com
- net income and valuation ratios data:
ACIU - Net Profit
Basic company analysis:ACIU, AC Immune Inc
Mass-produced product of AC Immune Corp

This indicator captures the net financial result, separating real operational efficiency from market expectations. Investors should interpret sharp fluctuations as signals of hidden costs or potential entry points. By analyzing the business profitability of the company on GURU.Markets, one can identify patterns between expenses and revenues. For AC Immune (ACIU), this metric depends directly on successes in Alzheimer's disease therapy. The partnership with Eli Lilly determines the long-term sustainability of profits.

Key competitors

Company Net Income Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Net Profit|Net Profit regencellbioscience.com|Net Profit AXSM|Net Income ACADIA Pharma ACAD|Xenon Pharmaceuticals Inc - Net Income|Final Profit VKTX|Supernus Pharmaceuticals - Net Profit|Net Financial Result catalystpharma.com CPRX|Denali Therapeutics Inc. (DNLI) - Company Net Income|Net Income Harmony Biosciences Inc|Company Net Income Biohaven Pharmaceutical|Net Income Amylyx Corp (AMLX)|Net Income TRVI (Trevi Therapeutics)|Net Profit praxismedicines.com (PRAX)|Company Net Income Anavex Life Sciences Corp. AVXL|CBLL: Company Profit|Prothena Biosciences - Net Profit|Company Net Income Alector, Inc.|ANNX: Net Profit|Omeros (OMER) - Net Profit|NGNE (Neurogene) - Net Profit|Net Income Voyager Therapeutics Inc (VYGR)|Net Profit NMRA|Net Financial Result Scilex Holding Company, Inc.|Tevogen Bio Holdings - Net Income|Net Profit Alpha Cognition Inc ACOG|CGTX - Company Net Income|IKT (Inhibikase Therapeutics Inc) - Company Profit|SAVA: Net Profit|Company Net Income Assertio (ASRT)|Net Income COYA|Net Profit VistaGen Therapeutics Inc|Company Net Income Ovid Therapeutics Inc. (OVID)|ABOS (Acumen Pharmaceuticals Inc.) - Final Profit|Company Net Income CervoMed Inc CRVO|Alterity Therapeutics Ltd. (ATHE) - Company Net Income|Clene Nanomedicine - Net Profit|PEPG - Net Profit|JUNS: Net Profit|Net Income Relmada Therapeutics Inc|Net Income ANVS|GRCE: Final Profit|Net Profit AIFF|Net Financial Result anewmeds.com|Company Net Income NeuroSense Therapeutics Ltd. NRSN|RVPH - Net Income|MTVA - Company Net Income|NeurAxis Inc (NRXS) - Net Income|HSDT (heliusmedical.com) - Net Income|Passage Bio (PASG) - Net Profit|Company Net Income Neuphoria Therapeutics, Inc.|Company Profit NERV (Minerva Neurosciences Inc)|Net Profit ATHA|ADXN - Company Net Income|Net Profit ALZN (Alzamend Neuro)|Net Profit Cyclerion Therapeutics Inc. CYCN|Protagenic - Net Profit|Pasithea Therapeutics (KTTA) - Net Income|CRGT: Net Profit|ATXI - Net Financial Result|Net Income BCLI|Net Profit caratherapeutics.com|Company Net Income Chromocell Therapeutics Corp. (CHRO)|eliemtx.com - Company Profit|Net Profit ITCI (Intra-Cellular Therapies, Inc.)|Longboard (LBPH) - Company Net Income|MRNS: Net Income|NKGN - Net Profit|NeuroBo Pharmaceuticals, Inc. (NRBO) - Company Net Income|Sage Therapeutics Inc. - Final Profit|Company Net Income Neurotrope|Company Net Income Trevena Inc TRVN|Net Profit VIGL|Net Profit Anew Medical Inc. (WENA)|Net Profit CERE (Cerevel Therapeutics, Inc.)